Generics

Originals

Biosimilars 10

Medical devices

Nutraceuticals

Filters

Pegfilgrastim manufacturers

10 products found

Filters

10 products found

pegfilgrastim

Injection, pre-filled syringe 6 mg/0.6 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP, WHO
Available for
Licensing with supply
Comments
Storage: 2-8 CDossier availability: Europe, Latin America, Emerging Market
Manufacturer #16394
This healthcare company is a prominent player in the pharmaceutical industry, specializing in a wide range of products including Active Pharmaceutical Ingredients (APIs), Biosimilars, Injectables, Ophthalmics, Peptides, and Solid Orals. They have a strong presence in both domestic and international markets, particularly in the EU and North America. The company boasts a diverse portfolio across several key therapy areas, with particular strength in Cardiovascular health and Oral Anti-Diabetic (OAD) medications. Their manufacturing facilities adhere to stringent GMP certifications, ensuring high quality standards. They also hold numerous product patents, highlighting their commitment to innovation.

Manufacturer usually replies in 2 days

pegfilgrastim

Injection 6 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Bangladesh
GMP approvals
WHO
Manufacturer #21340

The CTD dossier owner and manufacturer is a leading conglomerate with a diverse range of business operations across multiple industries. The website is structured to provide detailed financial information through sections like “Annual Report,” “Quarterly Report,” and “Price Sensitive Information,” which include links to various reports from recent years and updates on financial performance, such as notices about bond issuances. The company operates in several key sectors, including textiles, pharmaceuticals, personal protective equipment (PPE), ceramics, information and communication technology (ICT), real estate and trading, media, financial services, energy, and travel and tourism. As the largest entity within its group, the company plays a significant role in driving economic activities and growth across these industries, reflecting its strong market presence and commitment to diversified business interests.

Manufacturer usually replies in 2 days

pegfilgrastim

Injection 6 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Argentina
GMP approvals
PICS
Manufacturer #16454

A pharmaceutical company based in South America with 15+ years of experience in a drug market. More than 40 products in 25+ countries: LATAM; Wester, Southern and South-eastern Asia. Company’s therapeutic areas consist of products that can used in such areas as: urology, oncology, rare diseases and more.

Want to see all 10 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription
Pegfilgrastim is a form of protein used to stimulate the growth of "healthy" white blood cells in the bone marrow, once chemotherapy is given. White blood cells help the body fight infection. This is not a chemotherapy drug. It can also be used to stimulate the bone to produce more marrow and neutrophils to fight infection in patients receiving chemotherapy. Pegfilgrastim manufactures and suppliers market it under several brand names, including Neulasta among others. Pegfilgrastim was first developed by Amgen in 2002 was approved by FDA for use in the same year, in the same year, it was also approved for sale in the European continent. Dosage This medication is normally administered at least 24 hours after chemotherapy. It’s job is to stimulate the growth of new white blood cells. Pegfilgrastim is administered as a single injection. The injection can be given subcutaneously in pre-filled syringes. The dose is dictated by the ailment of the patients and condition. Cost of Pegfilgrastim The list price for Neulasta®, the most popular brand, is $8,500 per dose in the USA. Whereas in the UK, the Price for 6mg/0.6ml in a Pre-filled syringe is £411.83. How does it work? Chemotherapy and radiation therapy put a patient at risk for developing infections, anemia, and bleeding problems. The body's bone marrow produced blood cells of three major types. White blood cells for fighting infection. The Red blood cells carry oxygen to and remove waste products from organs and tissues, and the platelets, which enable blood clotting. Factors are substances that stimulate the body to create blood cells and boost their ability to function. The role of Pegfilgrastim is in stimulating blood cells, as they are the patient’s immune system during chemotherapy.Finding Pegfilgrastim Manufacturers and Pegfilgrastim Suppliers One of the fastest and easiest ways to find Pegfilgrastim manufacturers and Pegfilgrastim suppliers is to make use of Pipelinepharma's global B2B online marketplace for medicines and other pharmaceuticals. Usually, finding trusted manufacturers and supplies of specific drugs like Pegfilgrastim can be a time-consuming challenge, but with Pipelinepharma's simple search engine and network of proven partners, the whole process becomes a lot easier. All you need to do to get started is make use of our integrated search engine and start looking for suppliers or manufacturers of Pegfilgrastim to work with. You can fine-tune your search results using various filters too, letting you search for Pegfilgrastim from specific countries. Brand Names: Fulphila, Neulasta, Neulasta Onpro Kit, Udenyca, Ziextenzo Packagers: Amgen Inc., Physicians Total Care Inc Main companies: Amgen Inc, Harbin Pharm, Qilu Pharmaceutical, SL PHARM, Amoytop Bio, Hexal, Kirin Kunpeng (China) Bio-Pharmaceutical Co., Ltd., Chugai Pharmaceutical Co., Ltd., Novartis International AG, Pfizer Inc., Teva Pharmaceutical Industries Ltd, Dr. Reddys Laboratories, BIOCAD, Hospira, Intas Pharmaceuticals Limited, GenSci, Merck Group

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible